Bio-Rad Laboratories | BIO - الربح الإجمالي على المبيعات





الربح الإجمالي على المبيعات تغيير تاريخ
Abbott USD 5.86B 675M 2026-03
Agilent USD 990M 44M 2026-03
Becton, Dickinson and Co. USD 2.15B 257M 2026-03
Bio Techne USD 208.29M 17.01M 2026-03
Bio-Rad Laboratories USD 345.2M 1.8M 2025-12
Bruker USD 379.8M 69.4M 2026-03
Charles River Laboratories USD 279.32M 7.36M 2026-03
Danaher USD 3.59B 375M 2026-03
General Electric Aerospace USD 4.24B 439M 2026-03
Illumina USD 721M 38M 2026-03
IQVIA Holdings USD 1.07B 52M 2026-03
Laboratory Of America USD 1.01B 20.6M 2026-03
Merck USD 10.85B 2.57B 2025-12
Mettler Toledo International USD 675.44M 65.98M 2025-12
Myriad Genetics USD 146.8M 3M 2025-12
OraSure Technologies USD 11.34M 435K 2025-12
Pacific Biosciences Of California USD 15.74M 601K 2025-12
Quest Diagnostics USD 906M 33M 2026-03
Repligen USD 108.28M 4.45M 2026-03
Revvity USD 387.66M 34M 2026-03
Roche Holding CHF 22.09B 10.04B 2025-12
Siemens EUR 7.63B 471M 2025-12
Standard Biotools USD 11.31M 74K 2026-03
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Tosoh JPY 67.57B 10.89B 2025-09
Waters USD 542M 15.42M 2026-03